ARIAD PHARMACEUTICALS INC Research and Development Expense
ARIAD PHARMACEUTICALS INC reported Research and Development Expense of $43.63 million for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-08.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2016-11-08
- ARIAD PHARMACEUTICALS INC research and development expense for the quarter ending 2016-09-30 was $43.63M, a 9.53% decline year-over-year.
- ARIAD PHARMACEUTICALS INC research and development expense for the quarter ending 2016-06-30 was $42.86M, a 10.65% increase year-over-year.
- ARIAD PHARMACEUTICALS INC research and development expense for the quarter ending 2016-03-31 was $44.08M, a 11.75% increase year-over-year.
- ARIAD PHARMACEUTICALS INC research and development expense for the quarter ending 2015-12-31 was $44.81M, a 37.28% increase year-over-year.
- ARIAD PHARMACEUTICALS INC research and development expense for fiscal 2015 was $171.22M, a 41.98% increase from fiscal 2014.
- ARIAD PHARMACEUTICALS INC research and development expense for fiscal 2014 was $120.59M, a 25.97% decline from fiscal 2013.
- ARIAD PHARMACEUTICALS INC research and development expense for fiscal 2013 was $162.90M, a 12.57% increase from fiscal 2012.
- ARIAD PHARMACEUTICALS INC research and development expense for fiscal 2012 was $144.71M, a 86.14% increase from fiscal 2011.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2016-09-30 | $43.63M 10-Q · filed 2016-11-08 | $86.49M derived: sum of 2 quarters · filed 2016-11-08 | $130.57M 10-Q · filed 2016-11-08 | $175.38M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-06-30 | $42.86M 10-Q · filed 2016-08-08 | $86.94M 10-Q · filed 2016-08-08 | $131.76M derived: sum of 3 quarters · filed 2016-08-08 | $179.98M derived: sum of 4 quarters · filed 2016-11-08 |
| 2016-03-31 | $44.08M 10-Q · filed 2016-05-10 | $88.89M derived: sum of 2 quarters · filed 2016-05-10 | $137.11M derived: sum of 3 quarters · filed 2016-11-08 | $175.85M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-12-31 | $44.81M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $93.03M derived: sum of 2 quarters · filed 2016-11-08 | $131.77M derived: sum of 3 quarters · filed 2016-11-08 | $171.22M 10-K · filed 2016-02-29 |
| 2015-09-30 | $48.22M 10-Q · filed 2016-11-08 | $86.96M derived: sum of 2 quarters · filed 2016-11-08 | $126.40M 10-Q · filed 2016-11-08 | $159.05M derived: sum of 4 quarters · filed 2016-11-08 |
| 2015-06-30 | $38.74M 10-Q · filed 2016-08-08 | $78.18M 10-Q · filed 2016-08-08 | $110.83M derived: sum of 3 quarters · filed 2016-08-08 | $138.43M derived: sum of 4 quarters · filed 2016-08-08 |
| 2015-03-31 | $39.44M 10-Q · filed 2016-05-10 | $72.09M derived: sum of 2 quarters · filed 2016-05-10 | $99.69M derived: sum of 3 quarters · filed 2016-05-10 | $131.48M derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | $32.65M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $60.24M derived: sum of 2 quarters · filed 2016-02-29 | $92.04M derived: sum of 3 quarters · filed 2016-02-29 | $120.59M 10-K · filed 2016-02-29 |
| 2014-09-30 | $27.60M 10-Q · filed 2015-11-06 | $59.39M derived: sum of 2 quarters · filed 2015-11-06 | $87.95M 10-Q · filed 2015-11-06 | $123.77M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $31.79M 10-Q · filed 2015-08-07 | $60.35M 10-Q · filed 2015-08-07 | $96.17M derived: sum of 3 quarters · filed 2016-02-29 | $141.32M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $28.55M 10-Q · filed 2015-05-08 | $64.38M derived: sum of 2 quarters · filed 2016-02-29 | $109.52M derived: sum of 3 quarters · filed 2016-02-29 | $150.19M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $35.82M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $80.97M derived: sum of 2 quarters · filed 2016-02-29 | $121.64M derived: sum of 3 quarters · filed 2016-02-29 | $162.90M 10-K · filed 2016-02-29 |
| 2013-09-30 | $45.15M 10-Q · filed 2014-11-07 | $85.81M derived: sum of 2 quarters · filed 2014-11-07 | $127.08M 10-Q · filed 2014-11-07 | $164.76M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $40.67M 10-Q · filed 2014-08-08 | $81.93M 10-Q · filed 2014-08-08 | $119.62M derived: sum of 3 quarters · filed 2015-03-02 | $158.44M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $41.26M 10-Q · filed 2014-05-09 | $78.95M derived: sum of 2 quarters · filed 2015-03-02 | $117.77M derived: sum of 3 quarters · filed 2015-03-02 | $157.20M derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $37.69M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $76.51M derived: sum of 2 quarters · filed 2015-03-02 | $115.94M derived: sum of 3 quarters · filed 2015-03-02 | $144.71M 10-K · filed 2015-03-02 |
| 2012-09-30 | $38.82M 10-Q · filed 2013-11-12 | $78.25M derived: sum of 2 quarters · filed 2013-11-12 | $107.02M 10-Q · filed 2013-11-12 | $131.74M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $39.42M 10-Q · filed 2013-08-09 | $68.20M 10-Q · filed 2013-08-09 | $92.92M derived: sum of 3 quarters · filed 2014-03-03 | $112.61M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $28.77M 10-Q · filed 2013-05-10 | $53.50M derived: sum of 2 quarters · filed 2014-03-03 | $73.19M derived: sum of 3 quarters · filed 2014-03-03 | $91.94M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $24.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $44.41M derived: sum of 2 quarters · filed 2014-03-03 | $63.17M derived: sum of 3 quarters · filed 2014-03-03 | $77.74M 10-K · filed 2014-03-03 |
| 2011-09-30 | $19.69M 10-Q · filed 2012-11-09 | $38.45M derived: sum of 2 quarters · filed 2012-11-09 | $53.02M 10-Q · filed 2012-11-09 | $69.19M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $18.75M 10-Q · filed 2012-08-09 | $33.33M 10-Q · filed 2012-08-09 | $49.50M derived: sum of 3 quarters · filed 2013-03-01 | $62.66M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $14.57M 10-Q · filed 2012-05-09 | $30.74M derived: sum of 2 quarters · filed 2013-03-01 | $43.91M derived: sum of 3 quarters · filed 2013-03-01 | $57.72M derived: sum of 4 quarters · filed 2013-03-01 |
| 2010-12-31 | $16.17M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $29.34M derived: sum of 2 quarters · filed 2013-03-01 | $43.15M derived: sum of 3 quarters · filed 2013-03-01 | $57.98M 10-K · filed 2013-03-01 |
| 2010-09-30 | $13.17M 10-Q · filed 2011-11-07 | $26.98M derived: sum of 2 quarters · filed 2011-11-07 | $41.82M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | $13.81M 10-Q · filed 2011-08-09 | $28.65M 10-Q · filed 2011-08-09 | ||
| 2009-12-31 | $63.45M 10-K/A · filed 2012-03-30 |